Healthcare Industry News: DualCap
News Release - September 30, 2014
Catheter Connections Fails Additional Disinfection Test on Second Common Bacteria, Announces Ivera MedicalSAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Ivera Medical announced that an independent lab, in a second test, has found that the dark blue IV-Pole Strips and DualCap products for male luer connectors made by Catheter Connections failed to disinfect all critical surfaces of male luer connectors when used as directed on Pseudomonas aeruginosa. Last week, the results were published from an independent lab that found these same products failed to disinfect against P. aeruginosa, a gram-negative bacterium, and this second test was performed to understand the consistency of the problem. In this case, Catheter Connections' products failed to reach a 4-log reduction disinfection level on five of the twelve samples tested. The study report and related information for all of these tests can be found at www.curos.com.
"In all four tests performed by an independent lab, there has been a consistent problem with the inability of the Catheter Connections product to properly disinfect the male luer," said Bob Rogers, CEO of Ivera Medical. "As we think about the responsibility we have to the hospitals relying on the efficacy of the products we provide, the continued failure demonstrated by these lab studies should be a cause of concern."
In the same test, the Curos Tips product reached a 4-log reduction on all 12 samples tested, just as it has done on the three prior tests. "Disinfecting the male luer is a basic, yet critical requirement of these products and our product's disinfection performance is exceptional. The reality is, hospital products like male luers can be exposed to many pathogens and it is important that testing be done in a way that mirrors what happens in the clinical setting," said Mr. Rogers.
About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at www.curos.com
Source: Ivera Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.